New Lung Ultrasound Guidelines Split Diagnosis From Measurement in Critical Care

Point-of-care lung ultrasound has quietly become one of the most consequential bedside tools in modern intensive care, and two newly published evidence-based documents now attempt to bring order to its rapid expansion. Writing in Intensive Care Medicine, Giovanni Volpicelli, Luna Gargani and Laurent Zieleskiewicz review what has genuinely changed since the foundational 2012 international recommendations, drawing on a 2025 expert consensus on quantitative lung ultrasound in adults and children and a 2025 focused update of the original consensus for multidisciplinary clinical applications in adults. Their commentary is less a summary than a reading guide: it separates the advances that are real from those that are merely refinements, and it flags the boundaries that the formal statements leave compressed.

The central conceptual shift, according to the authors, is the explicit separation between the diagnostic and the quantitative uses of lung ultrasound. Both roles existed in 2012, but the new documents make clear that they demand different approaches and different techniques. Diagnosis answers a categorical question through a focused, pattern-based scan. Quantification translates findings into a reproducible measure through a standardized, multi-zone acquisition of the chest. The distinction matters because the two applications are easily conflated at the bedside, and the techniques that serve one do not automatically serve the other.

Quantification, the commentary stresses, does not concern aeration alone. Semi-quantitative techniques now extend to pulmonary congestion, pneumothorax volume and pleural effusion. In purely diagnostic applications, dividing the chest into zones and counting artifacts is usually unnecessary, with one exception: the differential diagnosis between diffuse and focal interstitial syndrome, assessed over the antero-lateral chest, where a criterion based on the number of positive zones provides a first orientation in the acutely ill patient. The quantitative techniques for aeration and congestion, by contrast, rest on zone division and apply semi-quantification to each scanned region.

The most substantial advance over 2012, the authors argue, is prognostic. A within-patient trajectory of repeated measurements enables monitoring, but it also underpins stratification that positions an individual patient’s risk relative to others. The commentary draws a careful line between two roles that are often blurred: as a prognostic tool, lung ultrasound predicts outcome, associating a measurement with a patient’s risk at a given moment; as a tool for treatment guidance, it informs a therapeutic decision and, through that decision, may alter the clinical course. The evidence base for the prognostic role, the authors note, is currently more robust than the evidence for treatment guidance.

A second structural novelty is the articulation of three diagnostic levels. The first concerns fundamental signs, for which the update refines nomenclature and definitions. The second, described as the genuine novelty, uses additional features to sharpen differential diagnosis between conditions that share the same elementary pattern: the distribution and quantity of B-lines, the characteristics of the pleural line, the correlation with clinical severity, the shape, margins, air bronchograms and size of consolidations, and the complexity of pleural effusion in relation to any associated consolidation. The third level is the final clinical interpretation, in which sonographic findings are integrated into a wider diagnostic puzzle where lung ultrasound may be decisive but should never be sufficient on its own.

The authors are explicit about why these levels need spelling out: they are too often collapsed in practice. A sign identified at the first level does not by itself deliver a diagnosis, and errors attributed to lung ultrasound frequently arise not in image acquisition but in the interpretation that follows. Competence in the technique and competence in clinical interpretation are distinct skills. The sonographic finding is a premise for reasoning, not a conclusion, and treating it as one is a recurring source of diagnostic misattribution.

Perhaps the most striking reframing concerns the power of exclusion. While confirming specific diagnoses, particularly in dedicated settings such as acute respiratory distress syndrome, is identified as one of the most promising future applications in intensive care, the commentary emphasizes the role of lung ultrasound in ruling conditions out and thereby narrowing the differential. This rule-out power rests on the high sensitivity, and therefore high negative predictive value, of the elementary signs: their absence renders the corresponding condition improbable even where a positive finding alone would not confirm it. Exclusion is typically achieved at the elementary-sign level, whereas confirmation requires the interpretive steps that follow.

The clinical applications where the new evidence bites hardest include heart failure and dialysis. In decompensated heart failure, the number of B-lines correlates with severity and predicts rehospitalization and death both at admission and at discharge, capturing residual, often subclinical congestion that clinical evaluation alone can miss. Because this prognostic value is independent of ejection fraction, it underscores the separation between cardiac function and cardiogenic congestion, and it extends to moderate-to-severe aortic stenosis, ST-elevation myocardial infarction and cardiogenic shock. In chronic heart failure, B-lines can also support therapeutic guidance: in one randomized trial, therapy titrated on sonographic monitoring reduced hospitalization for decompensation. In dialysis patients, sonographic congestion is often uncoupled from signs and symptoms, meaning an asymptomatic patient is not always euvolemic, and this occult overload predicts death and cardiac events. The authors caution, however, that there is not yet robust evidence that titrating fluid removal according to sonographic congestion during dialysis improves survival.

In mechanically ventilated patients, the lung aeration score monitors the effects of positive end-expiratory pressure, recruitment maneuvers and drugs, and carries prognostic weight, but it must be read alongside respiratory mechanics and gas exchange and is meaningful only when repeated acquisitions are rigorously standardized. The score provides no more than a coarse semi-quantification: it correlates with gold standards and with severity of lung involvement, yet it remains highly approximate because of the artifactual nature of the sonographic signs and the absence of a linear progression between score classes. A specific blind spot is overdistension, since overinflation of already aerated regions produces no change in the score; assessing reduced pleural sliding may eventually help close this gap. Lung ultrasound may also help select the ventilatory strategy itself: by distinguishing focal from non-focal lung morphology, it can guide a tailored approach assigning higher PEEP and recruitment maneuvers to non-focal ARDS and lower PEEP with prone positioning to focal ARDS, a strategy currently being compared with conventional ventilation in the ongoing PEGASUS trial.

The new guidelines also introduce, for the first time, an explicit distinction between aeration and congestion scores as separate techniques, validated in different populations against different gold standards and assessed over different chest regions, along with the concept of fluid tolerance: the absence of congestion signs defines a margin of safety for fluid administration. Fluid tolerance and fluid responsiveness are distinct questions, and lung ultrasound speaks to the former, functioning as a safety limit rather than a decision to give fluid, and is best complemented by focused cardiac ultrasound. Semi-quantification of pneumothorax, graded from the laterality of the lung point, and approximation of pleural effusion volume extend the same move from binary reading to graded measure, aiding decisions about drainage and enabling bedside monitoring without repeated radiographic exposure. The authors close with a caveat that doubles as a research agenda: prognostic weight is established, but validated numerical cut-offs for severity, characterization and prognosis in cardiogenic pulmonary edema, interstitial lung disease and ARDS are still missing, and that gap weighs most heavily on treatment guidance rather than prognosis.

Subject of Research: Updated evidence-based recommendations for diagnostic and quantitative point-of-care lung ultrasound in critical care

Article Title: What’s new in point-of-care lung ultrasound: reading the new recommendations

Article References: Volpicelli, G., Gargani, L., & Zieleskiewicz, L. (2026). What’s new in point-of-care lung ultrasound: reading the new recommendations. Intensive Care Medicine. https://doi.org/10.1007/s00134-026-08649-2

Image Credits: AI Generated

DOI: 10.1007/s00134-026-08649-2

Keywords: lung ultrasound, point-of-care ultrasound, intensive care, B-lines, ARDS, heart failure, aeration score, congestion, fluid tolerance, pneumothorax, pleural effusion, prognostication